Biosensing Chewing Gum for Oral Disease Detection: Study

The sensor is meant to trigger a bitter taste in the presence of inflammation-related enzymes. 

By | August 16, 2017

JULIUS-MAXIMILIANS-UNIVERSITÄT In a study published today (August 15) in Nature Communications, researchers demonstrate that a chewing gum equipped with a biosensor can be used to detect signs of oral disease.

Their sensor is triggered by certain disease-associated enzymes in the chewer’s saliva. These enzymes—matrix metalloproteinases—break the sensor apart by targeting the protease-cleavable fragment of the sensor. This frees a bitter taste-inducing substance.

The researchers tested their sensor on patients’ saliva, both from 19 patients with peri-implant disease and 14 healthy patients with non-diseased implants. Peri-implant disease is a disorder of modern dentistry, generally described as inflammation in the area surrounding a dental implant.

After dousing the sensor in the patients’ saliva, the authors demonstrated that healthy saliva induced significantly less cleavage of the biosensor than the spit from participants with inflammation.

“These platforms are not intended to rival sophisticated antibody-based screening tests let alone advanced next-generation sequencing technologies in terms of sensitivity or selectivity,” the researchers write in their report. It’s meant to give users a “heads-up” in the absence of other options.

To increase the potency of this bitter substance, the researchers created what they called a second-generation sensor. In this iteration, they engineered the cleaved fragment so that it could be cleaved once more by salivary aminopeptidases, enhancing bitterness.

The biosensing gum is yet to be tested in people. 

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. CRISPR to Debut in Clinical Trials
  4. Two Dozen House Republicans Do an About-Face on Tuition Tax